Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Delhi

    Tag: Delhi

    You Searched For "Delhi"
    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    PIL against Health Ministry notifying 8 medical devices as DRUGS, Delhi HC seeks Centre reply

    Medical Dialogues Bureau30 Sep 2019 12:24 PM GMT
    It was submitted that notifying blood monitoring devices, digital thermometers, nebulizers and glucometers as DRUGS will result in a substantial hike...
    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Farhat Nasim21 Sep 2019 9:51 AM GMT
    The Sub-Committee is of the opinion that there is an urgent need for defining the Over-the-Counter (OTC) drugs and to lay down specific provisions for...
    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Farhat Nasim1 Sep 2019 9:03 AM GMT
    New Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
    Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat

    Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat

    Farhat Nasim26 July 2019 9:30 AM GMT
    NEW DELHI: Days after ending a patent row over its cancer drug Regonat with Bayer, drugmaker, Natco Pharma is reported to have now been embroiled in a...
    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

    Farhat Nasim15 July 2019 9:22 AM GMT
    New Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
    Drug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; Details

    Drug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; Details

    Farhat Nasim8 July 2019 10:46 AM GMT
    New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared more than a dozen drugs as sub-standard in...
    Definition of generic drugs discussed in Parliament

    Definition of generic drugs discussed in Parliament

    Farhat Nasim7 July 2019 4:20 AM GMT
    He said that the generic medicines are generally those which contain some amount of same active ingredients in same dosage form, and are intended to...
    Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

    Delhi HC directs cashless service to all hospitals: GIPSA stayed on Ophthalmological Society petition

    Farhat Nasim13 Jun 2019 9:53 AM GMT
    New Delhi: Breaking the alleged cartel of public sector general insurance companies when it comes to mediclaim treatment, the Delhi High court has...
    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Farhat Nasim11 Jun 2019 10:01 AM GMT
    New Delhi: Bringing in a third party, the Delhi High Court has directed Radha Soami Satsang Beas (RSSB) chief Gurinder Singh Dhillon and his family...
    Medikabazaar to raise Rs 200 crore in Series B funding

    Medikabazaar to raise Rs 200 crore in Series B funding

    Garima29 May 2019 4:00 AM GMT
    This is being done as part of the Medikabazaar's growth and expansion plans to clock in $100 million in revenues in the financial year 2019-20, he...
    SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

    SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

    Meghna A Singhania15 May 2019 6:50 AM GMT
    Fortis made the submission in a recent affidavit filed in an ongoing case by Japanese drugmaker Daiichi Sankyo against the Singh brothers and their...
    Fortis tightens financial noose around Singh brothers; likely to move Delhi HC

    Fortis tightens financial noose around Singh brothers; likely to move Delhi HC

    Farhat Nasim11 May 2019 12:13 PM GMT
    New Delhi: Surrounded by controversies, Singh brothers is likely to face judicature as Fortis Healthcare Ltd (FHL) plans to a reach out to the Delhi...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X